The OMICRON variant of the COVID-19 virus, which has been spreading in the United States since late last year, has caused more damage than previous variants, including those who have been vaccinated and even those who have been amplified.
This is according to an analysis by the Washington Post’s Centers for Disease Control and Prevention, which found that 42% of those who died of COVID in January and February were vaccinated, compared with 23% of those who died in September, the delta option. still dominates.
The data are based on the date of infection and are limited to samples of cases in which vaccination status is known, the paper said. Older people and people with weakened immune systems are more likely to die. Almost two-thirds of those killed during the micron were 75 and older.
Omicron and its growing subvariants have been shown to be more infectious than previous strains. The increase in deaths is associated with vaccine protection, which slows down over time and makes it more difficult for patients at risk of contracting the disease.
Data also show that unvaccinated people are at a much higher risk than those who have been vaccinated, and that they are more likely to die if they become ill, and that they are at greater risk than those who have been shot.
Andrew Neumer, a professor of public health at the University of California, Irvine, who studied the deaths of COVID-19, told the newspaper, “It’s still dangerous not to be vaccinated.”
“The pandemic of unvaccinated people is wrong. If people are still symptomatic, they need to take care of prevention and action. ”
COVID cases are still rising in the U.S. after a sharp decline earlier this year. According to the New York Times tracker, the U.S. averages 60,953 cases per day, which is 55% more than two weeks ago. The country has an average of 17,220 hospital admissions per day, 16 percent more than two weeks ago, but still close to the lowest level since the first weeks of the pandemic. The average daily death toll dropped from 400 to 331.
As a sign of how the trend has changed, New York City raised its COVID risk level from low to medium on Monday. The city registers an average of 2,654 cases per day, compared to about 600 per day in early March. This number could be even higher because many people are now being tested at home and not all of the data has been collected.
Watch now: New subariants of omicron, found in small quantities in the United States in South Africa, have been affected
Vice President Kamala Harris will return to work on Tuesday after passing a negative test for COVID-19, her spokeswoman said.
“Today, the vice president was tested negative for COVID-19 in a rapid antigen test,” said spokeswoman Kirsten Allen. “According to the CDC guidelines, he wears a good mask when he is around others for ten days.”
Harris passed a positive test for COVID on April 26, and Allen said he would work at the White House after the then vice president passed a negative test for the virus.
Coronavirus News: The daily collection of MarketWatch keeps track of the latest developments every day since the onset of the coronavirus pandemic.
Other COVID-19 news you should know:
• According to the Associated Press, Beijing is preparing new hospitals to counter the increase in COVID-19 cases, but the number of new cases remains low. State media reported on Tuesday that a 1,000-bed hospital built for the 2003 SARS epidemic in Xiaotangshan, northeast of the city, had been repaired as needed. Unofficial reports say thousands of beds have been set up at the centralized quarantine center near the airport, but state media have not confirmed the preparations, which could be an attempt to prevent public threats.
• Shanghai is easing some of the coronavirus restrictions as the number of cases is reduced and the city is easing the severe blockade that was in its second month, Barron said. Nearly 2,000 companies in China’s financial center have been given the green light to resume work – even in limited circumstances, such as requiring workers to live in factories and have weekly, if not weekly, weekly nucleic acid checks.
• Pfizer PFE,
It announced stronger-than-expected earnings in the first quarter on Tuesday, boosted by sales of its COVID vaccine and antivirus. Revenue from the COVID vaccine increased from $ 3.2 billion to $ 13.2 billion, while sales of its antiviral Paxlovid increased to $ 1.5 billion. The company said it expects sales of the COVID vaccine to be about $ 32 billion in 2022 and sales of the virus to be about $ 22 billion.
• Wedbush analyst Dan Ives downgraded DocuSign’s DOCU e-signature rating,
A neutral low figure, citing an example of a more complex landscape for a company that was a big winner at the beginning of the pandemic. “[W]and believe that as the company expands to a wider CLM, the company is seeing a much harder sales environment [contract-lifecycle-management] The field is engaged in electronic signatures through the transition to big growth, “Ives wrote. The stock fell 2.8% last time.
Here’s what the numbers say
According to Johns Hopkins University, the global number of confirmed cases of COVID-19 on Friday exceeded 514.3 million, while the number of deaths exceeded 6.23 million.
The U.S. leads the world with 81.4 million cases and 994,013 deaths.
According to the Centers for Disease Control and Prevention, 219.8 million people in the United States have been fully vaccinated, or 66.2 percent of the total population. However, it increased by only 100.7 million, which is 45.8% of the vaccinated population.